16 December 2016 - AFT Pharmaceuticals, the Auckland-based drug-maker, will have to re-apply to Pharmac for a heart medicine supply contract it won in July 2015 after suffering disrupted supply over the past year.

In 2015, AFT was awarded the sole supply contract for metoprolol succinate, a beta-blocker used to treat angina, high blood pressure and heart failure, with the deal set to run from July 2016 until June 30, 2018. Today, Pharmac put out a request for proposals (RFP) for sole and dual supply of four strengths of the tablets for community pharmacies and district health board hospitals.

Read New Zealand Herald article